EWCZ Quote, Financials, Valuation and Earnings

Hims & Hers Health has a net margin of 2.67% compared to European Wax Center's net margin of 18.82%. European Wax Center's return on equity of 9.59% beat Hims & Hers Health's return on equity of 27.83%.

European Wax Center has a consensus price target of $8.31, signalling upside risk potential of 34.94%. On the other hand Hims & Hers Health has an analysts' consensus of $24.90 which suggests that it could fall by -12.59%. Given that European Wax Center has higher upside potential than Hims & Hers Health, analysts believe European Wax Center is more attractive than Hims & Hers Health.

European Wax Center has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.247, suggesting its more volatile than the S&P 500 by 24.726%.

European Wax Center has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. European Wax Center pays 31.9% of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

European Wax Center quarterly revenues are $55.4M, which are smaller than Hims & Hers Health quarterly revenues of $401.6M. European Wax Center's net income of $1.5M is lower than Hims & Hers Health's net income of $75.6M. Notably, European Wax Center's price-to-earnings ratio is 26.83x while Hims & Hers Health's PE ratio is 64.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for European Wax Center is 1.33x versus 5.22x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.

Kenvue has a net margin of 2.67% compared to European Wax Center's net margin of 9.82%. European Wax Center's return on equity of 9.59% beat Kenvue's return on equity of 9.94%.

European Wax Center has a consensus price target of $8.31, signalling upside risk potential of 34.94%. On the other hand Kenvue has an analysts' consensus of $22.44 which suggests that it could grow by 13.43%. Given that European Wax Center has higher upside potential than Kenvue, analysts believe European Wax Center is more attractive than Kenvue.

European Wax Center has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

European Wax Center has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.73% to investors and pays a quarterly dividend of $0.21 per share. European Wax Center pays 31.9% of its earnings as a dividend. Kenvue pays out 874.64% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Kenvue's is not.

European Wax Center quarterly revenues are $55.4M, which are smaller than Kenvue quarterly revenues of $3.9B. European Wax Center's net income of $1.5M is lower than Kenvue's net income of $383M. Notably, European Wax Center's price-to-earnings ratio is 26.83x while Kenvue's PE ratio is 39.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for European Wax Center is 1.33x versus 2.70x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health has a net margin of 2.67% compared to European Wax Center's net margin of -23.21%. European Wax Center's return on equity of 9.59% beat The Beauty Health's return on equity of -41.24%.

European Wax Center has a consensus price target of $8.31, signalling upside risk potential of 34.94%. On the other hand The Beauty Health has an analysts' consensus of -- which suggests that it could grow by 9.34%. Given that European Wax Center has higher upside potential than The Beauty Health, analysts believe European Wax Center is more attractive than The Beauty Health.

European Wax Center has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

European Wax Center has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. European Wax Center pays 31.9% of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

European Wax Center quarterly revenues are $55.4M, which are smaller than The Beauty Health quarterly revenues of $78.8M. European Wax Center's net income of $1.5M is higher than The Beauty Health's net income of -$18.3M. Notably, European Wax Center's price-to-earnings ratio is 26.83x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for European Wax Center is 1.33x versus 0.61x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.

Waldencast PLC has a net margin of 2.67% compared to European Wax Center's net margin of --. European Wax Center's return on equity of 9.59% beat Waldencast PLC's return on equity of -9.22%.

European Wax Center has a consensus price target of $8.31, signalling upside risk potential of 34.94%. On the other hand Waldencast PLC has an analysts' consensus of -- which suggests that it could grow by 44.36%. Given that Waldencast PLC has higher upside potential than European Wax Center, analysts believe Waldencast PLC is more attractive than European Wax Center.

European Wax Center has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Waldencast PLC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

European Wax Center has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. European Wax Center pays 31.9% of its earnings as a dividend. Waldencast PLC pays out -- of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

European Wax Center quarterly revenues are $55.4M, which are larger than Waldencast PLC quarterly revenues of --. European Wax Center's net income of $1.5M is higher than Waldencast PLC's net income of --. Notably, European Wax Center's price-to-earnings ratio is 26.83x while Waldencast PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for European Wax Center is 1.33x versus 1.68x for Waldencast PLC. Usually stocks with elevated PS ratios are considered overvalued.